ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Eptifibatide
C35H49N11O9S2
832 g/mol
API

(11-(4-Carbamimidamidobutyl)-3-carbamoyl-20-((1H-indol-3-yl)methyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosin-17-yl)acetic acid

CAS148031-34-9
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is a cyclic peptide with a disulfide bridge, featuring multiple amide bonds and aromatic rings. It is primarily used as an active pharmaceutical ingredient in drug manufacturing.

pharmaceutical manufacturingresearch compound for peptide-based drug development

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Vosoritide

CAS1480724-61-5

pharmaceutical raw material

ReferenceSame Category

Tramadol hydrochloride

CAS148229-78-1

pharmaceutical raw material

ReferenceSame Category

(S,S)-tramadol hydrochloride

CAS148229-79-2

pharmaceutical raw material

ReferenceSame Category

(+)-O-desmethyl tramadol hydrochloride

CAS148262-77-5

pharmaceutical raw material

Referencestereoisomer of

Eptifibatide

CAS188627-80-7

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-[20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid

InChIKey

CZKPOZZJODAYPZ-UHFFFAOYSA-N

SMILES

C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N

Synonyms (10)
  • Eptifibatide (INN)
  • Eptifibatide Acetate
  • Integrilin (TN)

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→